Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
boston blog main
boston top stories
deals
investing
5
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
fda
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
clinical trials
cstone pharmaceuticals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
new york blog main
new york top stories
nonalcoholic steatohepatitis
raleigh-durham blog main
raleigh-durham top stories
roche
san diego blog main
san diego top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
aegle therapeutics
aligos therapeutics
alzheimer's disease
amag pharmaceuticals
What
cancer
5
×
drug
roundup
amid
bio
bombast
caught
coronavirus
debate
develop
discussion
efforts
medicines
meso’s
miss
pandemic
pfizer’s
presidential
promise
response
tuesday’s
vaccine
viewers
ahead
ambien
american
annual
approval
asco
attendees
attention
biotech
blueprint
camp’s
candidate
cash
chicago
city
clinical
combinations
Language
unset
Current search:
biotech
×
cancer
×
investing
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More